Biotin Alone or a Science-Driven Nutraceutical Multi-Targeted Approach?

September 2019 | Volume 18 | Issue 9 | Features | 952 | Copyright © September 2019

Valerie D. Callender MD,a,b Danamarie Belpulsi MDc

 

ªCallender Dermatology and Cosmetic Center, Glen Dale, MD

BHoward University College of Medicine, Washington, DC 

cNutraceutical Wellness Inc, New York, NY

2. U.S. Food and Drug Administration. The FDA Warns that Biotin May Interfere with Lab Tests: FDA Safety Communication. November 28, 2017.

3. U.S. Food and Drug Administration. FDA In Brief: FDA provides draft recommendations to diagnostic manufacturers to help reduce risks of biotin interference with certain lab tests. June 13, 2019.

4. Sadick NS, Callender VD, Kircik LH, Kogan S. New insight into the pathophysiology of hair loss trigger a paradigm shift in the treatment approach. J Drugs Dermatol. 2017;16:135-140.

5. Farris PK, Rodgers N, McMichael A, Kogan S. A novel multi-targeting approach to treating hair loss, using standardized nutraceuticals. J Drugs Dermatol. 2017;16:141-148.

6. Ablon G, Kogan, S. A six-month, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of a nutraceutical supplement for promoting hair growth in women with self-perceived thinning hair. J Drugs Dermatol. 2018;17:58-565.

AUTHOR CORRESPONDENCE

Danamarie Belpulsi MD Danamarie@nutrafol.com